Antidiabetics Market Size, Revenue, Growth, Trend & Forecast Analysis, 2020 - 2027, By Antidiabetics Product Outlook, By Insulin Product Outlook, By Country, & By Region

  • Report Id: HCDHR 2259
  • Published Date: August, 2020
  • No of Pages: 150
  • Format: Electronic (PDF)
  • Publisher: DataHorizzon Research
  • Category:

Antidiabetics Market Report Overview

Antidiabetics market garnered a revenue of USD 65.41 billion in the year 2019 globally and has been foreseen to yield USD 120.41 billion by the year 2027 at a compound annual growth (CAGR) of 8.8% over the forecast period. The market has been observed to be growing at a steady growth rate over the last three years, however with the impact of COVID-19 pandemic globally, the business conditions are expected to change. The market size may reduce significantly or increase with a spike depending on how the value chain has been affected in the entire process.

Players that are operational in the market for a longer period of time are anticipated to absorb the sudden changes, losses and increased operational costs better than those who have recently entered the market. The report focuses on numerous factors that are anticipated to impact the market growth directly and indirectly. The report categorically analyses the growth patterns of different segments based on multiple derivation models.

Both the qualitative and quantitative aspects have been covered under the report. The antidiabetics market report includes market size, drivers, restraints, opportunities and trends that will help you understand the market dynamics in detail. Moreover, the report will include market estimates & forecasts in terms of revenue for the overall market along with the segments mentioned in the study. The report focuses on providing a holistic view of the entire market scenario from multiple unmatched detailed analysis mentioned in the report.

What to expect from the report?

  • Antidiabetics Total Available Market (TAM) Size
  • Antidiabetics Serviceable Available Market (SAM) Size
  • Business Implications of COVID-19 on the Overall Market
  • Market Share/ Revenue Share (%) of Top Market Players in Total Market Size (2019)
  • Market Size & Forecast (2016-2027) At Country & Regional Level, By Segments
  • Overview & Analysis of Key Players Operating in the Market

Key Highlights: 

Parameters

Description

COVID-19

Impact of COVID-19 on overall business scenario

Antidiabetics Market Revenue 2020

Global market revenue in 2020 will be derived taking into various micro & macro level factors; along with COVID-19 pandemic

Competitive Analysis

Company Market Share Analysis, 2019 (%)

Supply Chain Analysis

Analysis pertaining to several participants of supply chain such as raw material suppliers, distributors, & OEMs along with others will be highlighted in the study

Data Source

Primary & Secondary Research, Internal Data Base & Company Annual Reports

Regions Included

North America, Europe, Asia Pacific, Latin America, & Middle East & Africa

Countries Included

U.S., Canada, U.K., Germany, France, Mexico, Brazil, China, India, Japan, South Korea, UAE, South Africa

Table of Contents
Chapter 1. Research Methodology & Data Sources
1.1. Data Analysis Models
1.2. Research Scope & Assumptions
1.3. List of Primary & Secondary Data Sources
Chapter 2. Executive Summary
Chapter 3. Antidiabetics Market: Industry Analysis
3.1. Market segmentation
3.2. Supply chain analysis
3.3. Porter’s 5 forces analysis
3.4. PEST analysis
3.5. Market Dynamics
3.5.1. Market driver analysis
3.5.2. Market restraint analysis
3.5.3. Market opportunity analysis
3.6. Company Market Share Analysis, 2019
Chapter 4. Antidiabetics Market: Antidiabetics Product Outlook Insights
4.1. Global Antidiabetics Product Outlook Historic Market Data & Future Forecasts, 2016-2027
4.2. Alpha-glucosidase inhibitors
4.2.1. Historic Market Data & Future Forecasts, 2016-2027
4.2.2. Historic Market Data & Future Forecasts by Region, 2016-2027
4.3. Biguanides
4.3.1. Historic Market Data & Future Forecasts, 2016-2027
4.3.2. Historic Market Data & Future Forecasts by Region, 2016-2027
4.4. Sulphonylureas
4.4.1. Historic Market Data & Future Forecasts, 2016-2027
4.4.2. Historic Market Data & Future Forecasts by Region, 2016-2027
4.5. GLP-1 agonist
4.5.1. Historic Market Data & Future Forecasts, 2016-2027
4.5.2. Historic Market Data & Future Forecasts by Region, 2016-2027
4.6. Meglitinides
4.6.1. Historic Market Data & Future Forecasts, 2016-2027
4.6.2. Historic Market Data & Future Forecasts by Region, 2016-2027
4.7. DPP-4 inhibitors
4.7.1. Historic Market Data & Future Forecasts, 2016-2027
4.7.2. Historic Market Data & Future Forecasts by Region, 2016-2027
4.8. SGLT – 2
4.8.1. Historic Market Data & Future Forecasts, 2016-2027
4.8.2. Historic Market Data & Future Forecasts by Region, 2016-2027
4.9. Thiazolidinediones
4.9.1. Historic Market Data & Future Forecasts, 2016-2027
4.9.2. Historic Market Data & Future Forecasts by Region, 2016-2027

Chapter 5. Antidiabetics Market: Insulin Product Outlook Insights
5.1. Global Insulin Product Outlook Historic Market Data & Future Forecasts, 2016-2027
5.2. Rapid-acting
5.2.1. Historic Market Data & Future Forecasts, 2016-2027
5.2.2. Historic Market Data & Future Forecasts by Region, 2016-2027
5.3. Long-acting
5.3.1. Historic Market Data & Future Forecasts, 2016-2027
5.3.2. Historic Market Data & Future Forecasts by Region, 2016-2027
5.4. Premixed
5.4.1. Historic Market Data & Future Forecasts, 2016-2027
5.4.2. Historic Market Data & Future Forecasts by Region, 2016-2027
5.5. Premixed analog
5.5.1. Historic Market Data & Future Forecasts, 2016-2027
5.5.2. Historic Market Data & Future Forecasts by Region, 2016-2027
5.6. Short-acting
5.6.1. Historic Market Data & Future Forecasts, 2016-2027
5.6.2. Historic Market Data & Future Forecasts by Region, 2016-2027
5.7. Intermediate-acting
5.7.1. Historic Market Data & Future Forecasts, 2016-2027
5.7.2. Historic Market Data & Future Forecasts by Region, 2016-2027
Chapter 6. Antidiabetics Market: Regional Insights
6.1. Global Antidiabetics Market Data & Future Forecasts, By Region 2016-2027
6.2. North America
6.2.1. Historic Market Data & Future Forecasts, 2016-2027
6.2.2. Historic Market Data & Future Forecasts, By Antidiabetics Product Outlook, 2016-2027
6.2.3. Historic Market Data & Future Forecasts, By Insulin Product Outlook, 2016-2027
6.2.4. U.S.
6.2.4.1. Historic Market Data & Future Forecasts, 2016-2027
6.2.4.2. Historic Market Data & Future Forecasts, By Antidiabetics Product Outlook, 2016-2027
6.2.4.3. Historic Market Data & Future Forecasts, By Insulin Product Outlook, 2016-2027
6.2.5. Canada
6.2.5.1. Historic Market Data & Future Forecasts, 2016-2027
6.2.5.2. Historic Market Data & Future Forecasts, By Antidiabetics Product Outlook, 2016-2027
6.2.5.3. Historic Market Data & Future Forecasts, By Insulin Product Outlook, 2016-2027
6.3. Europe
6.3.1. Historic Market Data & Future Forecasts, 2016-2027
6.3.2. Historic Market Data & Future Forecasts, By Antidiabetics Product Outlook, 2016-2027
6.3.3. Historic Market Data & Future Forecasts, By Insulin Product Outlook, 2016-2027
6.3.4. U.K.
6.3.4.1. Historic Market Data & Future Forecasts, 2016-2027
6.3.4.2. Historic Market Data & Future Forecasts, By Antidiabetics Product Outlook, 2016-2027
6.3.4.3. Historic Market Data & Future Forecasts, By Insulin Product Outlook, 2016-2027
6.3.5. Germany
6.3.5.1. Historic Market Data & Future Forecasts, 2016-2027
6.3.5.2. Historic Market Data & Future Forecasts, By Antidiabetics Product Outlook, 2016-2027
6.3.5.3. Historic Market Data & Future Forecasts, By Insulin Product Outlook, 2016-2027
6.3.6. France
6.3.6.1. Historic Market Data & Future Forecasts, 2016-2027
6.3.6.2. Historic Market Data & Future Forecasts, By Antidiabetics Product Outlook, 2016-2027
6.3.6.3. Historic Market Data & Future Forecasts, By Insulin Product Outlook, 2016-2027
6.4. Asia Pacific
6.4.1. Historic Market Data & Future Forecasts, 2016-2027
6.4.2. Historic Market Data & Future Forecasts, By Antidiabetics Product Outlook, 2016-2027
6.4.3. Historic Market Data & Future Forecasts, By Insulin Product Outlook, 2016-2027
6.4.4. China
6.4.4.1. Historic Market Data & Future Forecasts, 2016-2027
6.4.4.2. Historic Market Data & Future Forecasts, By Antidiabetics Product Outlook, 2016-2027
6.4.4.3. Historic Market Data & Future Forecasts, By Insulin Product Outlook, 2016-2027
6.4.5. India
6.4.5.1. Historic Market Data & Future Forecasts, 2016-2027
6.4.5.2. Historic Market Data & Future Forecasts, By Antidiabetics Product Outlook, 2016-2027
6.4.5.3. Historic Market Data & Future Forecasts, By Insulin Product Outlook, 2016-2027
6.4.6. Japan
6.4.6.1. Historic Market Data & Future Forecasts, 2016-2027
6.4.6.2. Historic Market Data & Future Forecasts, By Antidiabetics Product Outlook, 2016-2027
6.4.6.3. Historic Market Data & Future Forecasts, By Insulin Product Outlook, 2016-2027
6.4.7. South Korea
6.4.7.1. Historic Market Data & Future Forecasts, 2016-2027
6.4.7.2. Historic Market Data & Future Forecasts, By Antidiabetics Product Outlook, 2016-2027
6.4.7.3. Historic Market Data & Future Forecasts, By Insulin Product Outlook, 2016-2027
6.5. Latin America
6.5.1. Historic Market Data & Future Forecasts, 2016-2027
6.5.2. Historic Market Data & Future Forecasts, By Antidiabetics Product Outlook, 2016-2027
6.5.3. Historic Market Data & Future Forecasts, By Insulin Product Outlook, 2016-2027
6.5.4. Brazil
6.5.4.1. Historic Market Data & Future Forecasts, 2016-2027
6.5.4.2. Historic Market Data & Future Forecasts, By Antidiabetics Product Outlook, 2016-2027
6.5.4.3. Historic Market Data & Future Forecasts, By Insulin Product Outlook, 2016-2027
6.5.5. Mexico
6.5.5.1. Historic Market Data & Future Forecasts, 2016-2027
6.5.5.2. Historic Market Data & Future Forecasts, By Antidiabetics Product Outlook, 2016-2027
6.5.5.3. Historic Market Data & Future Forecasts, By Insulin Product Outlook, 2016-2027
6.6. Middle East & Africa
6.6.1. Historic Market Data & Future Forecasts, 2016-2027
6.6.2. Historic Market Data & Future Forecasts, By Antidiabetics Product Outlook, 2016-2027
6.6.3. Historic Market Data & Future Forecasts, By Insulin Product Outlook, 2016-2027
6.6.4. UAE
6.6.4.1. Historic Market Data & Future Forecasts, 2016-2027
6.6.4.2. Historic Market Data & Future Forecasts, By Antidiabetics Product Outlook, 2016-2027
6.6.4.3. Historic Market Data & Future Forecasts, By Insulin Product Outlook, 2016-2027
6.6.5. South Africa
6.6.5.1. Historic Market Data & Future Forecasts, 2016-2027
6.6.5.2. Historic Market Data & Future Forecasts, By Antidiabetics Product Outlook, 2016-2027
6.6.5.3. Historic Market Data & Future Forecasts, By Insulin Product Outlook, 2016-2027
Chapter 7. Company Profiles
7.1. Pfizer
7.1.1. Company Description
7.1.2. Financial Highlights
7.1.3. Product Portfolio
7.1.4. Strategic Initiatives
7.2. Halozyme Therapeutics
7.2.1. Company Description
7.2.2. Financial Highlights
7.2.3. Product Portfolio
7.2.4. Strategic Initiatives
7.3. Bristol-Myers Squibb
7.3.1. Company Description
7.3.2. Financial Highlights
7.3.3. Product Portfolio
7.3.4. Strategic Initiatives
7.4. Novo Nordisk
7.4.1. Company Description
7.4.2. Financial Highlights
7.4.3. Product Portfolio
7.4.4. Strategic Initiatives
7.5. Merck & Co. Inc.
7.5.1. Company Description
7.5.2. Financial Highlights
7.5.3. Product Portfolio
7.5.4. Strategic Initiatives
7.6. Oramed Pharmaceuticals Inc.
7.6.1. Company Description
7.6.2. Financial Highlights
7.6.3. Product Portfolio
7.6.4. Strategic Initiatives
7.7. Eli Lilly
7.7.1. Company Description
7.7.2. Financial Highlights
7.7.3. Product Portfolio
7.7.4. Strategic Initiatives
7.8. Takeda Pharmaceuticals
7.8.1. Company Description
7.8.2. Financial Highlights
7.8.3. Product Portfolio
7.8.4. Strategic Initiatives
7.9. Sanofi Aventis
7.9.1. Company Description
7.9.2. Financial Highlights
7.9.3. Product Portfolio
7.9.4. Strategic Initiatives

List of Tables
Table 1 Antidiabetics Market Market Data & Future Forecasts, 2016-2027 (USD Million)
Table 2 Antidiabetics Market Data & Future Forecasts, By Region, 2016-2027 (USD Million)
Table 3 Antidiabetics Market Data & Future Forecasts, By Antidiabetics Product Outlook, 2016-2027 (USD Million)
Table 4 Antidiabetics Market Data & Future Forecasts, By Insulin Product Outlook, 2016-2027 (USD Million)
Table 5 Alpha-glucosidase inhibitors Market Data & Future Forecasts, 2016-2027 (USD Million)
Table 6 Biguanides Market Data & Future Forecasts, 2016-2027 (USD Million)
Table 7 Sulphonylureas Market Data & Future Forecasts, 2016-2027 (USD Million)
Table 8 GLP-1 agonist Market Data & Future Forecasts, 2016-2027 (USD Million)
Table 9 Meglitinides Market Data & Future Forecasts, 2016-2027 (USD Million)
Table 10 DPP-4 inhibitors Market Data & Future Forecasts, 2016-2027 (USD Million)
Table 11 SGLT – 2 Market Data & Future Forecasts, 2016-2027 (USD Million)
Table 12 Thiazolidinediones Market Data & Future Forecasts, 2016-2027 (USD Million)
Table 13 Rapid-acting Market Data & Future Forecasts, 2016-2027 (USD Million)
Table 14 Long-acting Market Data & Future Forecasts, 2016-2027 (USD Million)
Table 15 Premixed Market Data & Future Forecasts, 2016-2027 (USD Million)
Table 16 Premixed analog Market Data & Future Forecasts, 2016-2027 (USD Million)
Table 17 Short-acting Market Data & Future Forecasts, 2016-2027 (USD Million)
Table 18 Intermediate-acting Market Data & Future Forecasts, 2016-2027 (USD Million)
Table 19 North America Antidiabetics Market Data & Future Forecasts, 2016-2027 (USD Million)
Table 20 North America Antidiabetics Market Data & Future Forecasts, By Antidiabetics Product Outlook, 2016-2027 (USD Million)
Table 21 North America Antidiabetics Market Data & Future Forecasts, By Insulin Product Outlook, 2016-2027 (USD Million)
Table 22 U.S. Antidiabetics Market Data & Future Forecasts, 2016-2027 (USD Million)
Table 23 U.S. Antidiabetics Market Data & Future Forecasts, By Antidiabetics Product Outlook, 2016-2027 (USD Million)
Table 24 U.S. Antidiabetics Market Data & Future Forecasts, By Insulin Product Outlook, 2016-2027 (USD Million)
Table 25 Canada Antidiabetics Market Data & Future Forecasts, 2016-2027 (USD Million)
Table 26 Canada Antidiabetics Market Data & Future Forecasts, By Antidiabetics Product Outlook, 2016-2027 (USD Million)
Table 27 Canada Antidiabetics Market Data & Future Forecasts, By Insulin Product Outlook, 2016-2027 (USD Million)
Table 28 Europe Antidiabetics Market Data & Future Forecasts, 2016-2027 (USD Million)
Table 29 Europe Antidiabetics Market Data & Future Forecasts, By Antidiabetics Product Outlook, 2016-2027 (USD Million)
Table 30 Europe Antidiabetics Market Data & Future Forecasts, By Insulin Product Outlook, 2016-2027 (USD Million)
Table 31 U.K. Antidiabetics Market Data & Future Forecasts, 2016-2027 (USD Million)
Table 32 U.K Antidiabetics Market Data & Future Forecasts, By Antidiabetics Product Outlook, 2016-2027 (USD Million)
Table 33 U.K Antidiabetics Market Data & Future Forecasts, By Insulin Product Outlook, 2016-2027 (USD Million)
Table 34 Germany Antidiabetics Market Data & Future Forecasts, 2016-2027 (USD Million)
Table 35 Germany Antidiabetics Market Data & Future Forecasts, By Antidiabetics Product Outlook, 2016-2027 (USD Million)
Table 36 Germany Antidiabetics Market Data & Future Forecasts, By Insulin Product Outlook, 2016-2027 (USD Million)
Table 37 France Antidiabetics Market Data & Future Forecasts, 2016-2027 (USD Million)
Table 38 France Antidiabetics Market Data & Future Forecasts, By Antidiabetics Product Outlook, 2016-2027 (USD Million)
Table 39 France Antidiabetics Market Data & Future Forecasts, By Insulin Product Outlook, 2016-2027 (USD Million)
Table 40 Asia Pacific Antidiabetics Market Data & Future Forecasts, 2016-2027 (USD Million)
Table 41 Asia Pacific Antidiabetics Market Data & Future Forecasts, By Antidiabetics Product Outlook, 2016-2027 (USD Million)
Table 42 Asia Pacific Antidiabetics Market Data & Future Forecasts, By Insulin Product Outlook, 2016-2027 (USD Million)
Table 43 China Antidiabetics Market Data & Future Forecasts, 2016-2027 (USD Million)
Table 44 China Antidiabetics Market Data & Future Forecasts, By Antidiabetics Product Outlook, 2016-2027 (USD Million)
Table 45 China Antidiabetics Market Data & Future Forecasts, By Insulin Product Outlook, 2016-2027 (USD Million)
Table 46 India Antidiabetics Market Data & Future Forecasts, 2016-2027 (USD Million)
Table 47 India Antidiabetics Market Data & Future Forecasts, By Antidiabetics Product Outlook, 2016-2027 (USD Million)
Table 48 India Antidiabetics Market Data & Future Forecasts, By Insulin Product Outlook, 2016-2027 (USD Million)
Table 49 Japan Antidiabetics Market Data & Future Forecasts, 2016-2027 (USD Million)
Table 50 Japan Antidiabetics Market Data & Future Forecasts, By Antidiabetics Product Outlook, 2016-2027 (USD Million)
Table 51 Japan Antidiabetics Market Data & Future Forecasts, By Insulin Product Outlook, 2016-2027 (USD Million)
Table 52 South Korea Antidiabetics Market Data & Future Forecasts, 2016-2027 (USD Million)
Table 53 South Korea Antidiabetics Market Data & Future Forecasts, By Antidiabetics Product Outlook, 2016-2027 (USD Million)
Table 54 South Korea Antidiabetics Market Data & Future Forecasts, By Insulin Product Outlook, 2016-2027 (USD Million)
Table 55 Latin America Antidiabetics Market Data & Future Forecasts, 2016-2027 (USD Million)
Table 56 Latin America Antidiabetics Market Data & Future Forecasts, By Antidiabetics Product Outlook, 2016-2027 (USD Million)
Table 57 Latin America Antidiabetics Market Data & Future Forecasts, By Insulin Product Outlook, 2016-2027 (USD Million)
Table 58 Brazil Antidiabetics Market Data & Future Forecasts, 2016-2027 (USD Million)
Table 59 Brazil Antidiabetics Market Data & Future Forecasts, By Antidiabetics Product Outlook, 2016-2027 (USD Million)
Table 60 Brazil Antidiabetics Market Data & Future Forecasts, By Insulin Product Outlook, 2016-2027 (USD Million)
Table 61 Mexico Antidiabetics Market Data & Future Forecasts, 2016-2027 (USD Million)
Table 62 Mexico Antidiabetics Market Data & Future Forecasts, By Antidiabetics Product Outlook, 2016-2027 (USD Million)
Table 63 Mexico Antidiabetics Market Data & Future Forecasts, By Insulin Product Outlook, 2016-2027 (USD Million)
Table 64 Middle East & Africa Antidiabetics Market Data & Future Forecasts, 2016-2027 (USD Million)
Table 65 Middle East & Africa Antidiabetics Market Data & Future Forecasts, By Antidiabetics Product Outlook, 2016-2027 (USD Million)
Table 66 Middle East & Africa Antidiabetics Market Data & Future Forecasts, By Insulin Product Outlook, 2016-2027 (USD Million)
Table 67 UAE Antidiabetics Market Data & Future Forecasts, 2016-2027 (USD Million)
Table 68 UAE Antidiabetics Market Data & Future Forecasts, By Antidiabetics Product Outlook, 2016-2027 (USD Million)
Table 69 UAE Antidiabetics Market Data & Future Forecasts, By Insulin Product Outlook, 2016-2027 (USD Million)
Table 70 South Africa Antidiabetics Market Data & Future Forecasts, 2016-2027 (USD Million)
Table 71 South Africa Antidiabetics Market Data & Future Forecasts, By Antidiabetics Product Outlook, 2016-2027 (USD Million)
Table 72 South Africa Antidiabetics Market Data & Future Forecasts, By Insulin Product Outlook, 2016-2027 (USD Million)

List of Figures
Fig.1 Data Analysis Model
Fig.2 Antidiabetics Market, by 2016-2027 (USD Million)
Fig.3 Antidiabetics Market Segmentation
Fig.4 Supply chain analysis
Fig.5 Antidiabetics Market Driver Anlaysis
Fig.6 Antidiabetics Market Restraint Analysis
Fig.7 Antidiabetics Market Opportunity Analysis
Fig.8 Porters 5 Forces Model
Fig.9 PEST Analysis- Antidiabetics Market
Fig.10 Company Market Share Analysis, 2019

Antidiabetics Market Segmentation:

Antidiabetics Market, By Antidiabetics Product Outlook (2016-2027)

  • Alpha-glucosidase inhibitors
  • Biguanides
  • Sulphonylureas
  • GLP-1 agonist
  • Meglitinides
  • DPP-4 inhibitors
  • SGLT – 2
  • Thiazolidinediones

Antidiabetics Market, By Insulin Product Outlook (2016-2027)

  • Rapid-acting
  • Long-acting
  • Premixed
  • Premixed analog
  • Short-acting
  • Intermediate-acting

Antidiabetics Market, By Region (2016-2027)

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • France
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
  • Latin America
    • Brazil
    • Mexico
  • Middle East & Africa
    • UAE
    • South Africa

Major Players Operating in the Antidiabetics Market:

  • Pfizer
  • Halozyme Therapeutics
  • Bristol-Myers Squibb
  • Novo Nordisk
  • Merck & Co. Inc.
  • Oramed Pharmaceuticals Inc.
  • Eli Lilly
  • Takeda Pharmaceuticals
  • Sanofi Aventis

Choose License Type

Single user
$3,960
Multi User
$4,950
Enterprise User
$5,940
Clear

Each market study on Reports Globe will be revised based on COVID-19 impact analysis

How can we help you?

Our salient features

Best Solution

We will help you understand value propositions of various reports across numerous domains and suggest the best possible solution to suffice your research needs.

Customized Research

Our team of analysts and consultants provide assistance for customized research requirements

Max ROI

Guaranteed maximum assistance to help you get your reports at the optimum prices, thereby ensuring maximum returns on investment.

24/7 Support

24X7 availability to help you through the buying process as well as answer any of your doubts.

We've Received Your Request

We Thank You for filling out your requirements. Our sales team will get in touch with you shortly.